Congreso ESMO 2019

Barcelona, España – 27 Sept – 1 Oct 2019

Oncomatryx presentará en el Congreso ESMO 2019 sus datos más interesantes de OMTX705 ADC el 3o de Septiembre en la Sesión de Poster de Inmunoterapia para cáncer  (Hall 4) bajo el titulo.“Tumor stroma targeting and modulation by OMTX705 ADC, a novel and potent immunotherapeutic treatment of solid tumors”.


Si va a asistir a la convención y desea acordar una reunión, puede rellenar el formulario adjunto.

Your Name (required)

Your Email (required)

Your Comments

By continuing to use the site, you agree to the use of cookies. Continue, scroll or accept. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.